{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:24:20Z","timestamp":1784838260164,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011272","name":"EC | EC Seventh Framework Programm | FP7 Health","doi-asserted-by":"publisher","award":["603131"],"award-info":[{"award-number":["603131"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"EC | EC Seventh Framework Programm | FP7 Health","doi-asserted-by":"publisher","award":["603131"],"award-info":[{"award-number":["603131"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2016T008"],"award-info":[{"award-number":["2016T008"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EC | EC Seventh Framework Programm | FP7 Health"},{"DOI":"10.13039\/501100006006","name":"Royal Netherlands Academy of Arts and Sciences | ICIN Netherlands Heart Institute","doi-asserted-by":"publisher","award":["CVON2017-20"],"award-info":[{"award-number":["CVON2017-20"]}],"id":[{"id":"10.13039\/501100006006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular diseases form the most common cause of death worldwide, with atherosclerosis as main etiology. Atherosclerosis is marked by cholesterol rich lipoprotein deposition in the artery wall, evoking a pathogenic immune response. Characteristic for the disease is the pathogenic accumulation of macrophages in the atherosclerotic lesion, which become foam cells after ingestion of large quantities of lipoproteins. We hypothesized that, by inducing a CD8 T cell response towards lipoprotein derived apolipoprotein-B100 (ApoB100), lesional macrophages, that are likely to cross-present lipoprotein constituents, can specifically be eliminated. Based on<jats:italic>in silico<\/jats:italic>models for protein processing and MHC-I binding, 6 putative CD8 T cell epitopes derived from ApoB100 were synthesized. HLA-A2 binding was confirmed for all peptides by T2 cell binding assays and recall responses after vaccination with the peptides proved that 5 of 6 peptides could induce CD8 T cell responses. Induction of ApoB100 specific CD8 T cells did not impact plaque size and cellular composition in HLA-A2 and human ApoB100 transgenic LDLr<jats:sup>\u2212\/\u2212<\/jats:sup>mice. No recall response could be detected in cultures of cells isolated from the aortic arch, which were observed in cell cultures of splenocytes and mesenteric lymph nodes, suggesting that the atherosclerotic environment impairs CD8 T cell activation.<\/jats:p>","DOI":"10.1038\/s41598-019-53642-z","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:02:26Z","timestamp":1574420546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model"],"prefix":"10.1038","volume":"9","author":[{"given":"Frank H.","family":"Schaftenaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Amersfoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde","family":"Douna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara J.","family":"Kr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Foks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-1959","authenticated-orcid":false,"given":"Ilze","family":"Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram A.","family":"Sl\u00fctter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs H. M.","family":"van Puijvelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Drijfhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"53642_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117\u2013171 (2015).","journal-title":"Lancet"},{"key":"53642_CR2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.humpath.2008.04.018","volume":"39","author":"J Gewaltig","year":"2008","unstructured":"Gewaltig, J., Kummer, M., Koella, C., Cathomas, G. & Biedermann, B. C. Requirements for CD8 T-cell migration into the human arterial wall. Hum. Pathol. 39, 1756\u20131762 (2008).","journal-title":"Hum. Pathol."},{"key":"53642_CR3","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1161\/ATVBAHA.111.237081","volume":"31","author":"J-C Grivel","year":"2011","unstructured":"Grivel, J.-C. et al. Activation of T Lymphocytes in Atherosclerotic Plaques. Arterioscler. Thromb. Vasc. Biol. 31, 2929\u20132937 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53642_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.112.001347","volume":"127","author":"T Kyaw","year":"2013","unstructured":"Kyaw, T. et al. Cytotoxic and Proinflammatory CD8+ T Lymphocytes Promote Development of Vulnerable Atherosclerotic Plaques in ApoE-Deficient Mice. Circulation 127, 1028\u20131039 (2013).","journal-title":"Circulation"},{"key":"53642_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/CIRCRESAHA.117.304611","volume":"117","author":"C Cochain","year":"2015","unstructured":"Cochain, C. et al. CD8 + T Cells Regulate Monopoiesis and Circulating Ly6C high Monocyte Levels in Atherosclerosis in MiceNovelty and Significance. Circ. Res. 117, 244\u2013253 (2015).","journal-title":"Circ. Res."},{"key":"53642_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOL.0000000000000475","volume":"29","author":"J van Duijn","year":"2018","unstructured":"van Duijn, J., Kuiper, J. & Sl\u00fctter, B. The many faces of CD8+ T cells in atherosclerosis. Curr. Opin. Lipidol. 29, 1 (2018).","journal-title":"Curr. Opin. Lipidol."},{"key":"53642_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/cvr\/cvy261","volume":"115","author":"J van Duijn","year":"2019","unstructured":"van Duijn, J. et al. CD8+ T-cells contribute to lesion stabilization in advanced atherosclerosis by limiting macrophage content and CD4+ T-cell responses. Cardiovasc. Res. 115, 729\u2013738 (2019).","journal-title":"Cardiovasc. Res."},{"key":"53642_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","volume":"62","author":"H-W Mittr\u00fccker","year":"2014","unstructured":"Mittr\u00fccker, H.-W., Visekruna, A. & Huber, M. Heterogeneity in the Differentiation and Function of CD8+ T Cells. Arch. Immunol. Ther. Exp. (Warsz). 62, 449\u2013458 (2014).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)."},{"key":"53642_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.18.1.275","volume":"18","author":"JT Harty","year":"2000","unstructured":"Harty, J. T., Tvinnereim, A. R. & White, D. W. CD8+ T Cell Effector Mechanisms in Resistance to Infection. Annu. Rev. Immunol. 18, 275\u2013308 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"53642_CR10","doi-asserted-by":"publisher","first-page":"8941260","DOI":"10.1155\/2016\/8941260","volume":"2016","author":"J Reiser","year":"2016","unstructured":"Reiser, J. & Banerjee, A. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response. J. Immunol. Res. 2016, 8941260 (2016).","journal-title":"J. Immunol. Res."},{"key":"53642_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","volume":"38","author":"S Halle","year":"2017","unstructured":"Halle, S., Halle, O. & F\u00f6rster, R. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. Trends Immunol. 38, 432\u2013443 (2017).","journal-title":"Trends Immunol."},{"key":"53642_CR12","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/ATVBAHA.107.143743","volume":"27","author":"AD Hauer","year":"2007","unstructured":"Hauer, A. D. et al. Vaccination Against VEGFR2 Attenuates Initiation and Progression of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2050\u20132057 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53642_CR13","doi-asserted-by":"publisher","first-page":"e30780","DOI":"10.1371\/journal.pone.0030780","volume":"7","author":"K-Y Chyu","year":"2012","unstructured":"Chyu, K.-Y. et al. CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide. PLoS One 7, e30780 (2012).","journal-title":"PLoS One"},{"key":"53642_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/cvr\/cvn025","volume":"78","author":"EJA van Wanrooij","year":"2008","unstructured":"van Wanrooij, E. J. A. et al. Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice. Cardiovasc. Res. 78, 590\u2013596 (2008).","journal-title":"Cardiovasc. Res."},{"key":"53642_CR15","doi-asserted-by":"publisher","first-page":"e005318","DOI":"10.1161\/JAHA.116.005318","volume":"6","author":"PC Dimayuga","year":"2017","unstructured":"Dimayuga, P. C. et al. Identification of apoB\u2010100 Peptide\u2010Specific CD8+ T Cells in Atherosclerosis. J. Am. Heart Assoc. 6, e005318 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"53642_CR16","doi-asserted-by":"publisher","first-page":"12752","DOI":"10.1073\/pnas.220427097","volume":"97","author":"B Ludewig","year":"2000","unstructured":"Ludewig, B. et al. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl. Acad. Sci. 97, 12752\u201312757 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"53642_CR17","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1161\/ATVBAHA.111.227140","volume":"31","author":"S Yamada","year":"2011","unstructured":"Yamada, S. et al. Apoptosis Signal-Regulating Kinase 1 Deficiency Accelerates Hyperlipidemia-Induced Atheromatous Plaques via Suppression of Macrophage Apoptosis. Arterioscler. Thromb. Vasc. Biol. 31, 1555\u20131564 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53642_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","volume":"25","author":"J Liu","year":"2004","unstructured":"Liu, J. et al. Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice. Arterioscler. Thromb. Vasc. Biol. 25, 174\u20139 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53642_CR19","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1172\/JCI117622","volume":"94","author":"AI Fyfe","year":"1994","unstructured":"Fyfe, A. I., Qiao, J. H. & Lusis, A. J. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J. Clin. Invest. 94, 2516\u20132520 (1994).","journal-title":"J. Clin. Invest."},{"issue":"Suppl","key":"53642_CR20","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1194\/jlr.R800056-JLR200","volume":"50","author":"LK Curtiss","year":"2009","unstructured":"Curtiss, L. K. & Tobias, P. S. Emerging role of Toll-like receptors in atherosclerosis. J. Lipid Res. 50(Suppl), S340\u20135 (2009).","journal-title":"J. Lipid Res."},{"key":"53642_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/ATVBAHA.111.224873","volume":"32","author":"EA Van Vre","year":"2012","unstructured":"Van Vre, E. A., Ait-Oufella, H., Tedgui, A. & Mallat, Z. Apoptotic Cell Death and Efferocytosis in Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 887\u2013893 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53642_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLIMM.2017.11.028","author":"D Corridoni","year":"2017","unstructured":"Corridoni, D. & Simmons, A. Innate immune receptors for cross-presentation: The expanding role of NLRs. Mol. Immunol. https:\/\/doi.org\/10.1016\/J.MOLIMM.2017.11.028 (2017).","journal-title":"Mol. Immunol."},{"key":"53642_CR23","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.4049\/jimmunol.159.11.5391","volume":"159","author":"M Bellone","year":"1997","unstructured":"Bellone, M. et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159, 5391\u20139 (1997).","journal-title":"J. Immunol."},{"key":"53642_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.immunol.17.1.51","volume":"17","author":"JW Yewdell","year":"1999","unstructured":"Yewdell, J. W. & Bennink, J. R. Immunodominance in major histocompatibility complex class I\u2013restricted t lymphocyte responses. Annu. Rev. Immunol. 17, 51\u201388 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"53642_CR25","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/eji.1830221033","volume":"22","author":"G Stuber","year":"1992","unstructured":"Stuber, G. et al. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur. J. Immunol. 22, 2697\u20132703 (1992).","journal-title":"Eur. J. Immunol."},{"key":"53642_CR26","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","volume":"171","author":"B Peters","year":"2003","unstructured":"Peters, B., Bulik, S., Tampe, R., Van Endert, P. M. & Holzh\u00fctter, H.-G. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J. Immunol. 171, 1741\u20139 (2003).","journal-title":"J. Immunol."},{"key":"53642_CR27","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00018-005-4528-2","volume":"62","author":"S Tenzer","year":"2005","unstructured":"Tenzer, S. et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell. Mol. Life Sci. 62, 1025\u201337 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"53642_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1215","volume":"24","author":"M Moutaftsi","year":"2006","unstructured":"Moutaftsi, M. et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24, 817\u2013819 (2006).","journal-title":"Nat. Biotechnol."},{"key":"53642_CR29","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","volume":"2","author":"M Nielsen","year":"2007","unstructured":"Nielsen, M. et al. NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence. PLoS One 2, e796 (2007).","journal-title":"PLoS One"},{"key":"53642_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-6-132","volume":"6","author":"B Peters","year":"2005","unstructured":"Peters, B. & Sette, A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6, 132 (2005).","journal-title":"BMC Bioinformatics"},{"key":"53642_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","volume":"62","author":"S Buus","year":"2003","unstructured":"Buus, S. et al. Sensitive quantitative predictions of peptide-MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach. Tissue Antigens 62, 378\u201384 (2003).","journal-title":"Tissue Antigens"},{"key":"53642_CR32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/bioinformatics\/btn128","volume":"24","author":"C Lundegaard","year":"2008","unstructured":"Lundegaard, C., Lund, O. & Nielsen, M. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 24, 1397\u20131398 (2008).","journal-title":"Bioinformatics"},{"key":"53642_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen, M. et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12, 1007\u20131017 (2003).","journal-title":"Protein Sci."},{"key":"53642_CR34","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkn202","volume":"36","author":"C Lundegaard","year":"2008","unstructured":"Lundegaard, C. et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36, W509\u201312 (2008).","journal-title":"Nucleic Acids Res."},{"key":"53642_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1745-7580-4-2","volume":"4","author":"J Sidney","year":"2008","unstructured":"Sidney, J. et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4, 2 (2008).","journal-title":"Immunome Res."},{"key":"53642_CR36","doi-asserted-by":"crossref","unstructured":"Pascolo, S. et al. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J. Exp. Med. 185, 2043\u201351 (1997).","DOI":"10.1084\/jem.185.12.2043"},{"key":"53642_CR37","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI1847","volume":"101","author":"J Boren","year":"1998","unstructured":"Boren, J. et al. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J. Clin. Invest. 101, 1084\u201393 (1998).","journal-title":"J. Clin. Invest."},{"key":"53642_CR38","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1172\/JCI116927","volume":"92","author":"MF Linton","year":"1993","unstructured":"Linton, M. F. et al. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92, 3029\u201337 (1993).","journal-title":"J. Clin. Invest."},{"key":"53642_CR39","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00262-012-1259-8","volume":"61","author":"K Barrios","year":"2012","unstructured":"Barrios, K. & Celis, E. TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Cancer Immunol. Immunother. 61, 1307\u20131317 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"53642_CR40","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.1158\/0008-5472.CAN-09-2019","volume":"69","author":"H-I Cho","year":"2009","unstructured":"Cho, H.-I. & Celis, E. Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects. Cancer Res. 69, 9012\u20139019 (2009).","journal-title":"Cancer Res."},{"key":"53642_CR41","doi-asserted-by":"publisher","first-page":"e1043504","DOI":"10.1080\/2162402X.2015.1043504","volume":"4","author":"H-I Cho","year":"2015","unstructured":"Cho, H.-I., Jung, S.-H., Sohn, H.-J., Celis, E. & Kim, T.-G. An optimized peptide vaccine strategy capable of inducing multivalent CD8+ T cell responses with potent antitumor effects. Oncoimmunology 4, e1043504 (2015).","journal-title":"Oncoimmunology"},{"key":"53642_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.immuni.2016.01.010","volume":"44","author":"S Halle","year":"2016","unstructured":"Halle, S. et al. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity. Immunity 44, 233\u2013245 (2016).","journal-title":"Immunity"},{"key":"53642_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.atherosclerosis.2012.07.033","volume":"224","author":"I Bergstr\u00f6m","year":"2012","unstructured":"Bergstr\u00f6m, I., Backteman, K., Lundberg, A., Ernerudh, J. & Jonasson, L. Persistent accumulation of interferon-\u03b3-producing CD8+CD56+ T cells in blood from patients with coronary artery disease. Atherosclerosis 224, 515\u2013520 (2012).","journal-title":"Atherosclerosis"},{"key":"53642_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2016.03.038","volume":"249","author":"Y Hwang","year":"2016","unstructured":"Hwang, Y. et al. Expansion of CD8+ T cells lacking the IL-6 receptor \u03b1 chain in patients with coronary artery diseases (CAD). Atherosclerosis 249, 44\u201351 (2016).","journal-title":"Atherosclerosis"},{"key":"53642_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/joim.12038","volume":"274","author":"D Kolbus","year":"2013","unstructured":"Kolbus, D. et al. Association between CD8 + T-cell subsets and cardiovascular disease. J. Intern. Med. 274, 41\u201351 (2013).","journal-title":"J. Intern. Med."},{"key":"53642_CR46","doi-asserted-by":"publisher","first-page":"e1006457","DOI":"10.1371\/journal.pcbi.1006457","volume":"14","author":"W Zhao","year":"2018","unstructured":"Zhao, W. & Sher, X. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes. PLoS Comput. Biol. 14, e1006457 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"53642_CR47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.fob.2015.08.006","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction. FEBS Open Bio 5, 712\u20136 (2015).","journal-title":"FEBS Open Bio"},{"key":"53642_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/joim.12589","volume":"281","author":"A Gister\u00e5","year":"2017","unstructured":"Gister\u00e5, A. et al. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis. J. Intern. Med. 281, 383\u2013397 (2017).","journal-title":"J. Intern. Med."},{"key":"53642_CR49","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CDLI.8.3.628-631.2001","volume":"8","author":"SA Ghanekar","year":"2001","unstructured":"Ghanekar, S. A. et al. Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65. Clin. Diagn. Lab. Immunol. 8, 628\u201331 (2001).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"53642_CR50","first-page":"5004","volume":"186","author":"N Sakamoto","year":"2011","unstructured":"Sakamoto, N. & Rosenberg, A. S. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T. cells. 186, 5004\u201311 (2011).","journal-title":"cells."},{"key":"53642_CR51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.imbio.2010.11.003","volume":"216","author":"D Kolbus","year":"2011","unstructured":"Kolbus, D. et al. Immunization with cationized BSA inhibits progression of disease in ApoBec-1\/LDL receptor deficient mice with manifest atherosclerosis. Immunobiology 216, 663\u2013669 (2011).","journal-title":"Immunobiology"},{"key":"53642_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molimm.2010.10.005","volume":"48","author":"SM M\u00e4kel\u00e4","year":"2011","unstructured":"M\u00e4kel\u00e4, S. M., Osterlund, P. & Julkunen, I. TLR ligands induce synergistic interferon-\u03b2 and interferon-\u03bb1 gene expression in human monocyte-derived dendritic cells. Mol. Immunol. 48, 505\u201315 (2011).","journal-title":"Mol. Immunol."},{"key":"53642_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02186-9","volume":"8","author":"F Veglia","year":"2017","unstructured":"Veglia, F. et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat. Commun. 8, 2122 (2017).","journal-title":"Nat. Commun."},{"key":"53642_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13324","volume":"7","author":"MH den Brok","year":"2016","unstructured":"den Brok, M. H. et al. Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation. Nat. Commun. 7, 13324 (2016).","journal-title":"Nat. Commun."},{"key":"53642_CR55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2009.06.022","volume":"31","author":"L Bougn\u00e8res","year":"2009","unstructured":"Bougn\u00e8res, L. et al. A Role for Lipid Bodies in the Cross-presentation of Phagocytosed Antigens by MHC Class I in Dendritic Cells. Immunity 31, 232\u2013244 (2009).","journal-title":"Immunity"},{"key":"53642_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep15414","volume":"5","author":"B Legein","year":"2015","unstructured":"Legein, B. et al. Ablation of CD8\u03b1+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice. Sci. Rep. 5, 15414 (2015).","journal-title":"Sci. Rep."},{"key":"53642_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354 (2006).","journal-title":"Nature"},{"key":"53642_CR58","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"53642_CR59","doi-asserted-by":"publisher","first-page":"e0128523","DOI":"10.1371\/journal.pone.0128523","volume":"10","author":"M-K Qiu","year":"2015","unstructured":"Qiu, M.-K. et al. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis. PLoS One 10, e0128523 (2015).","journal-title":"PLoS One"},{"key":"53642_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2019.04.217","volume":"285","author":"Jvan Duijn","year":"2019","unstructured":"Duijn, Jvan et al. CD39 identifies a microenvironment-specific anti-inflammatory CD8+ T-cell population in atherosclerotic lesions. Atherosclerosis 285, 71\u201378 (2019).","journal-title":"Atherosclerosis"},{"key":"53642_CR61","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gkx760","volume":"46","author":"M Shugay","year":"2018","unstructured":"Shugay, M. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46, D419\u2013D427 (2018).","journal-title":"Nucleic Acids Res."},{"key":"53642_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature22383","volume":"547","author":"P Dash","year":"2017","unstructured":"Dash, P. et al. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547, 89\u201393 (2017).","journal-title":"Nature"},{"key":"53642_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"},{"key":"53642_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jim.2014.02.007","volume":"406","author":"W-J Shen","year":"2014","unstructured":"Shen, W.-J. et al. MHC binding prediction with KernelRLSpan and its variations. J. Immunol. Methods 406, 10\u201320 (2014).","journal-title":"J. Immunol. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53642-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T07:06:41Z","timestamp":1695452801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53642-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53642"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53642-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17391"}}